15 Seth Klarman Atara Biotherapeutics Trades
The first Atara Biotherapeutics trade was made in Q4 2014. Since then Seth Klarman bought shares ten more times and sold shares on four occasions. The investor sold all their shares in Q4 2023 and doesn't own any shares in Atara Biotherapeutics anymore.
Avg closing price
Price range
Sold -391 Thousand shares
Q4 2023
Avg closing price
$23.32
Price range
$5.75
-
$43.50
Increased shares by 7.1% (+26 Thousand shares)
Q2 2023
Avg closing price
$56.55
Price range
$37.50
-
$76.00
Increased shares by 12.3% (+40 Thousand shares)
Q1 2023
Avg closing price
$96.99
Price range
$70.00
-
$136.50
Sold 4.2% shares (-14.2 Thousand shares)
Q1 2022
Avg closing price
$318.44
Price range
$211.00
-
$422.25
Sold 6.9% shares (-25.3 Thousand shares)
Q1 2021
Avg closing price
$442.02
Price range
$350.00
-
$518.00
Sold 8.2% shares (-32.5 Thousand shares)
Q4 2020
Avg closing price
$461.61
Price range
$316.75
-
$655.75
Increased shares by 19.4% (+64.5 Thousand shares)
Q2 2020
Avg closing price
$252.61
Price range
$188.25
-
$373.25
Increased shares by 18.7% (+52.4 Thousand shares)
Q3 2019
Avg closing price
$373.12
Price range
$300.75
-
$498.50
Increased shares by 9.7% (+24.8 Thousand shares)
Q2 2019
Avg closing price
$705.84
Price range
$476.25
-
$1,026.00
Increased shares by 2.0% (+5.04 Thousand shares)
Q1 2019
Avg closing price
$929.14
Price range
$710.00
-
$1,043.50
Increased shares by 16.7% (+35.8 Thousand shares)
Q1 2018
Avg closing price
$911.27
Price range
$450.00
-
$1,208.75
Increased shares by 11.4% (+22 Thousand shares)
Q3 2015
Avg closing price
$1,219.64
Price range
$786.00
-
$1,577.75
Increased shares by 1.0% (+1.86 Thousand shares)
Q2 2015
Avg closing price
$1,147.29
Price range
$916.75
-
$1,600.50
Increased shares by 90.8% (+90.7 Thousand shares)
Q1 2015
Avg closing price
$660.88
Price range
$450.00
-
$1,072.50
New holding (+99.8 Thousand shares)
Q4 2014
Avg closing price
$611.48
Price range
$266.25
-
$795.00
News about Atara Biotherapeutics Inc and Seth Klarman
Seth Klarman''s Exit from Atara Biotherapeutics Inc
Seth Klarman''s Exit from Atara Biotherapeutics Inc
Hedge fund titan Seth Klarman boosted bets on 3 healthcare stocks and dumped tech giants in the 2nd quarter
Billionaire hedge fund manager Seth Klarman slimmed some of his biggest tech holdings and grew positions in healthcare stocks during the second quarter, new ...